Recent advances in cold atmospheric plasma (CAP) for breast cancer therapy
Cell Biology International · 2023-02 · 47 (2) · 327-340
DOI: 10.1002/cbin.11939 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Biology International, online erschienen am 07.11.2022. Verfasst von Supat Chupradit und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Therapy, Faculty of Associated Medical Sciences, Chiang Mai University, Suthep, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Breast Neoplasms, Plasma Gases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Abstract (Originalsprache)
The serious problems of conventional breast cancer therapy strategies such as drug resistance, severe side effects, and lack of selectivity prompted the development of various cold atmospheric plasma (CAP) devices. Due to its advanced technology, CAP can produce a unique environment rich in reactive oxygen and nitrogen species (RONS), photons, charged ions, and an electric field, making it a promising revolutionary platform for cancer therapy. Despite substantial technological successes, CAP‐based therapeutic systems are encounter with distinct limitations, including low control of the generated RONS, poor knowledge about its anticancer mechanisms, and challenges concerning designing, manufacturing, clinical translation, and commercialization, which must be resolved. The latest developments in CAP‐based therapeutic systems for breast cancer treatment are discussed in this review. More significantly, the integration of CAP‐based medicine approaches with other breast cancer therapies, including chemo‐ and nanotherapy is thoroughly addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational Therapy, Faculty of Associated Medical Sciences, Chiang Mai University, Suthep, Chiang Mai, Thailand.
- Universitas Krisnadwipayana, Universitas Indonesia, Jakarta, Indonesia.
- College of Dentistry, Al-Ayen University, Dhi-Qar, Iraq.
- Department of Propaedeutics of Dental Diseases, I.M. Sechenov First Moscow State Medical University, Moskva, Russia.
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj, Saudi Arabia.
- HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Faculty of Nursing, Bangkok, Thailand.
ORCID-Profile: Bahar Ghazi Esfahani
Zitieren
APA
Chupradit, S., Widjaja, G., Radhi Majeed, B., Kuznetsova, M., Ansari, M. J., Suksatan, W., Turki Jalil, A., & Ghazi Esfahani, B. (2023). Recent advances in cold atmospheric plasma (CAP) for breast cancer therapy. Cell Biology International, 47(2), 327-340. https://doi.org/10.1002/cbin.11939
Vancouver
Chupradit S, Widjaja G, Radhi Majeed B, Kuznetsova M, Ansari MJ, Suksatan W, et al. Recent advances in cold atmospheric plasma (CAP) for breast cancer therapy. Cell Biology International. 2023;47(2):327-340. doi:10.1002/cbin.11939
BibTeX
@article{Chupradit2023,
author = {Chupradit, Supat and Widjaja, Gunawan and Radhi Majeed, Basman and Kuznetsova, Maria and Ansari, Mohammad Javed and Suksatan, Wanich and Turki Jalil, Abduladheem and Ghazi Esfahani, Bahar},
title = {Recent advances in cold atmospheric plasma (CAP) for breast cancer therapy},
journal = {Cell Biology International},
year = {2023},
volume = {47},
number = {2},
pages = {327--340},
doi = {10.1002/cbin.11939}
}
EUVIMED